Limb-girdle muscular dystrophy 2J, Titin gene mutation (Q86066): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/437873883 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_437873883
Property / CURIE: CID11:ID_437873883 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_437873883
Property / Canary Token: dki-india-ID_437873883 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 11:25, 15 August 2026

Limb-girdle muscular dystrophy type 2J (LGMD2J) is caused by homozygous mutation in the titin gene, whereas heterozygous mutation in the titin gene causes tardive tibial muscular dystrophy. Mutation in the titin gene also causes dilated cardiomyopathy type 1G. Onset of the severe phenotype is in the first to third decades and involves weakness of all proximal muscles. Severe disability with loss of ambulation occurs within 20 years (third to sixth decades). There is no facial muscle involvement or cardiomyopathy. Some patients later develop distal muscle involvement.
Language Label Description Also known as
default for all languages
ID_437873883
    English
    Limb-girdle muscular dystrophy 2J, Titin gene mutation
    Limb-girdle muscular dystrophy type 2J (LGMD2J) is caused by homozygous mutation in the titin gene, whereas heterozygous mutation in the titin gene causes tardive tibial muscular dystrophy. Mutation in the titin gene also causes dilated cardiomyopathy type 1G. Onset of the severe phenotype is in the first to third decades and involves weakness of all proximal muscles. Severe disability with loss of ambulation occurs within 20 years (third to sixth decades). There is no facial muscle involvement or cardiomyopathy. Some patients later develop distal muscle involvement.

      Statements

      CID11:ID_437873883
      0 references
      dki-india-ID_437873883
      0 references
      Concluído
      0 references
      13 August 2026
      0 references